Subcutaneous nivolumab for treating advanced renal cell carcinoma after systemic treatment TSID 12008Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Signatera molecular residual disease assay (MT741)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC